Nana Yaa Boahene

Prosjektleder, ph.d.

Sekretariatet

Nana er prosjektleder for faggruppen for plantevernmidler. Hun er utdannet Dr. philos i toksikologi.

Curriculum Vitae

Stilling

Prosjektleder for faggruppen for plantevernmidler 

Utdanning

2003 – 2009: Dr. philos toksikologi, Univ. i Oslo, Oslo, Norge

1999 – 2001: M Phil medisinsk biologi, Univ. i Tromsø, Norge.

1993 – 1998: BSc biokjemi, Univ. of Science and Technology, Ghana.

Arbeidserfaring

2015 – dd: Prosjektleder, Vitenskapskomiteen for mat og miljø

2014 – 2014: Forsker, Direktoratet for strålevern og atomsikkerhet, Oslo, Norway.

2009 – 2014: Forsker, Nasjonalt Folkehelseinstitutet, Oslo, Norway.

2003 – 2008: Stipendiat, Nasjonalt Folkehelseinstitutet, Oslo, Norway.

2002 – 2003: Vitenskapelig Assistent, Genova As, Oslo, Norway.

1997 – 1997: Vitenskapelig assistent, Darko Farms Complex, Ghana.

1996 – 1996: Vitenskapelig assistent, Crops Research Institute, Ghana.

1992 – 1992: Lærer, Ghana Secondary School - National Service Scheme, Ghana.

Øvrig faglig bakgrunn

2023: «Protocol development - The EFSA scientific assessment principles and process», EFSA e-learning training course on horizontal scientific assessment methodologies.2023

2023: «The risk-benefit assessment framework - Principles of human health risk-benefit assessment of foods», EFSA e-learning training course on food safety risk assessment.

2023: «In-silico models and other relevant modeling approaches - Use of new-approach methodologies in chemical risk assessment», EFSA e-learning training course on food safety risk assessment.

2023: «Training on Open MCRA tool for cumulative risk assessment», EFSA/RIVM, Online.

2019: «Training course on Assessment of the environmental fate and behaviour of PPPs in soil, water and air», BTSF, Mechelen, Belgia.

2018: «Training course on Microbiological Risk Assessment», BTSF, Lisboa, Portugal.

2017: «Training course on Environmental Risk Assessment», BTSF, Rome Italy.

2017: Prosjektledelse II. NMBU, Ås, Norge.

2016: Kurs i Prosjektledelse. Prosjekt Forum, Oslo, Norge.

2015: «Training course on Risk Assessment Genetically Modified Organisms and other Biotechnologies», BTSF, Tallin, Estland.

2014:«Challenges in health risk assessment», Inst. for miljømedisin, Karolinska Inst.

2010: «Laboratory animal techniques and welfare - A competence course in rodent husbandry», FHI. Tilsvarende Felasa kategori C for forskere

Utvalgte publikasjoner

Nana Asare, Nur Duale, Hege H. Slagsvold, Birgitte Lindeman, Ann Karin Olsen, Joanna Gromadzka-Ostrowska, Sylwia Meczynska-Wielgosz, Marcin Kruszewski, Gunnar Brunborg, and Christine Instanes. Genotoxicity and gene expression modulation of silver and titanium dioxide nanoparticles in mice. Nanotoxicology, 10:3 (2016) 312-321

Nana Asare, Christine Instanes, Wiggo Sandberg, Magne Refnes, Per Schwarze, Marcin Kruszewski, Gunnar Brunborg. Cytotoxic and genotoxic effects of silver nanoparticles in testicular cells. Toxicology 291 (2012) 65-74

Nana Asare, Dominique Lagadic-Gossmann and Jørn A. Hølme. 3-Nitrofluoranthene (3-NF)-induced apoptsis and programmed necrosis. Autophagy 5 (2009) 754-755

Asare, M. Låg, D. Lagadic-Gossmann, M. Rissel, P. Schwarze, J. A. Holme. 3-Nitrofluoranthene but not 3-Aminofluoranthene elicit apoptosis as well as programmed necrosis in Hepa1c1c7 cells. Toxicology 255 (2009) 140-150

Asare, X. Tekpli M. Rissel, A. Solhaug, N. Landvik, V. Lecureur, G. Brunborg, M. Låg, D. Lagadic-Gossmann, J. A. Holme. Signalling pathways involved in 1-Nitropyrene- (1-NP) and 3-Nitrofluoranthene (3-NF)-induced cell death in Hepa1c1c7 cells. Mutagenesis 24 (2009) 481-493

Asare, N.E. Landvik, D. Lagadic-Gossmann, M. Rissel, X. Tekpli, K. Ask, M. Låg, J. A. Holme. 1-Nitropyrene induces apoptosis and apparently a non-apoptotic programmed cell death (paraptosis) in Hepa1c1c7 cells. Toxicology and Applied Pharmacology 230 (2008) 175–186

Asare N., Landvik N., Ask K., Rohrlack T. and Holme J.A. Metabolism of nitro-polycyclic aromatic hydrocarbons elicit apoptotic and necrotic responses in Hepa1c1c7 cells. Toxicology and Applied Pharmacology 197 (2004) 308